Therapeutic options in older patients with metastatic non-small cell lung cancer.
about
Meta-analysis comparing doublet and single cytotoxic agent therapy as first-line treatment in elderly patients with advanced nonsmall-cell lung cancer.Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer.Quantitative Proteomic Analysis of Optimal Cutting Temperature (OCT) Embedded Core-Needle Biopsy of Lung Cancer.A novel cyclometallated Pt(II)-ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation.
P2860
Therapeutic options in older patients with metastatic non-small cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@ast
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@en
type
label
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@ast
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@en
prefLabel
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@ast
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@en
P2860
P356
P1476
Therapeutic options in older patients with metastatic non-small cell lung cancer.
@en
P2093
Elisabeth Quoix
P2860
P304
P356
10.1177/1758834012455838
P577
2012-09-01T00:00:00Z